Our Story
We believe the future of fermentation is autonomous.
Most fermentation processes still rely on fixed protocols and manual intervention, limiting performance, consistency, and profitability.
Fermelogy was founded to change that.
We help manufacturers move beyond static execution and toward intelligent, real-time process optimization.
Our Technology
Morpheus is a software-only autonomous AI layer for fermentation.
It learns each process from historical data, builds a dedicated controller for that specific process, and continuously adapts production through thousands of real-time micro-decisions during every batch.
Operating within approved process limits and constraints, Morpheus works with existing infrastructure and requires no new hardware.
Our Impact
• Higher yield
• Lower production costs
• Stronger operational margins
• Better batch consistency
• Lower carbon footprint per unit produced
The Market Opportunity
Dynamic fermentation underpins a $90 billion addressable market today, spanning antibiotics, vaccines, antibodies, enzymes, amino acids, insulin, hormones, and alternative proteins. This market is projected to grow to $153 billion by 2035 (CAGR 5%).
Beyond direct revenues, these segments fuel end-product industries worth over $500 billion annually, from pharmaceuticals to food and cosmetics. As demand rises and sustainability pressures grow, Fermelogy’s AI Autopilot offers a unique opportunity to unlock hidden margins, modernize production, and secure a competitive edge.